Trident Texofab Limited (BOM:540726)

Trident Texofab Revenue

Trident Texofab had revenue of 280.77M INR in the quarter ending June 30, 2025, with 9.20% growth. This brings the company's revenue in the last twelve months to 1.24B, up 21.87% year-over-year. In the fiscal year ending March 31, 2025, Trident Texofab had annual revenue of 1.22B with 22.69% growth.

• Revenue (ttm): 1.24B
• Revenue Growth: +21.87%
• P/S Ratio: 2.99
• Revenue / Employee: 20.74M
• Employees: 60
• Market Cap: 3.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.22B	225.73M	22.69%
Mar 31, 2024	994.83M	31.27M	3.25%
Mar 31, 2023	963.56M	120.63M	14.31%
Mar 31, 2022	842.93M	343.67M	68.83%
Mar 31, 2021	499.27M	-410.38M	-45.11%